Novartis
NVS
NVS
1,346 hedge funds and large institutions have $15.8B invested in Novartis in 2025 Q2 according to their latest regulatory filings, with 116 funds opening new positions, 486 increasing their positions, 462 reducing their positions, and 72 closing their positions.
Holders
1,346
Holders Change
+8
Holders Change %
+0.6%
% of All Funds
18.08%
Holding in Top 10
16
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+14.29%
% of All Funds
0.21%
New
116
Increased
486
Reduced
462
Closed
72
Calls
$173M
Puts
$205M
Net Calls
-$31.6M
Net Calls Change
+$3.29M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$915M |
| 2 |
2
Optiver Holding
Amsterdam,
Netherlands
|
$62.3M |
| 3 |
3
Bank of Montreal
Toronto,
Ontario, Canada
|
$68.4M |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$1.1B |
| 5 |
5
Millennium Management
New York
|
$102M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
UOC
1426
UBS O'Connor
Chicago,
Illinois
| – | – | – | – |
|
|
ACM
1427
ADAR1 Capital Management
Austin,
Texas
| – | – | – | – |
|
1428
Tudor Investment Corp
Stamford,
Connecticut
| – | – | – | – |
|
1429
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|